Institutional Venture Management XVI Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UiPath
PATH
|
+$527M |
| 2 |
Hims & Hers Health
HIMS
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$93.1M |
| 2 |
Datadog
DDOG
|
+$36.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 87.32% |
| 2 | Healthcare | 12.68% |
Similar funds
Institutional Venture Management XVI's Q2 2021 Portfolio in Review
As of Q2 2021, Institutional Venture Management XVI held 4 positions worth $875M, up 95% from $448M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Institutional Venture Management XVI deployed $408M of net new capital in Q2 2021, opening 1 new position and adding to 1 existing holding. Its largest new stake was UiPath: 7,180,766 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 87% of assets, up from 73% a quarter earlier, followed by Healthcare.
On the sell side, the largest reduction was CrowdStrike, an estimated $93.1M trimmed.
- Institutional Venture Management XVI's largest Q2 2021 buy was UiPath: 7,180,766 shares worth $488M.
- Institutional Venture Management XVI added most to Hims & Hers Health in Q2 2021, an estimated $10.8M increase.
- Institutional Venture Management XVI's biggest Q2 2021 reduction was CrowdStrike, cutting an estimated $93.1M.
- Institutional Venture Management XVI's ten largest holdings make up 100% of its $875M portfolio in Q2 2021.
- Institutional Venture Management XVI opened 1 new position and closed 0 in Q2 2021.
- Institutional Venture Management XVI's portfolio value rose 95% quarter-over-quarter to $875M.
Based on Institutional Venture Management XVI's 13F filing for Q2 2021, filed 16 Aug 2021.